{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:51:01Z","timestamp":1790787061940,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.jaac.2011.01.007","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T22:30:34Z","timestamp":1299537034000},"page":"395-405","source":"Crossref","is-referenced-by-count":98,"title":["Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit\/Hyperactivity Disorder"],"prefix":"10.1016","volume":"50","author":[{"given":"Robert L.","family":"Findling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann C.","family":"Childress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gasior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hamdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Celeste","family":"Ferreira-Cornwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Squires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2011.01.007_bib1","series-title":"Diagnosis of attention deficit\/hyperactivity disorder","author":"Green","year":"1999"},{"key":"10.1016\/j.jaac.2011.01.007_bib2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1517\/14656566.6.6.1003","article-title":"Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD","volume":"6","author":"Weisler","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaac.2011.01.007_bib3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1542\/peds.108.4.1033","article-title":"Clinical practice guideline: treatment of the school-aged child with attention-deficit\/hyperactivity disorder","volume":"108","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2011.01.007_bib4","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/ajp.2007.164.6.942","article-title":"The worldwide prevalence of ADHD: a systematic review and metaregression analysis","volume":"164","author":"Polanczyk","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2011.01.007_bib5","first-page":"209","article-title":"Overview of epidemiology, clinical features, genetics, neurobiology, and prognosis of adolescent attention-deficit\/hyperactivity disorder","volume":"19","author":"Schubiner","year":"2008","journal-title":"Adolesc Med State Art Rev"},{"issue":"Suppl 1","key":"10.1016\/j.jaac.2011.01.007_bib6","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1136\/adc.2004.059006","article-title":"The effect of ADHD on the life of an individual, their family, and community from preschool to adult life","volume":"90","author":"Harpin","year":"2005","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaac.2011.01.007_bib7","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0031-3955(03)00077-4","article-title":"Attention-deficit\/hyperactivity disorder evaluation and diagnosis","volume":"50","author":"Reiff","year":"2003","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.jaac.2011.01.007_bib8","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/00004583-200111000-00008","article-title":"Attention-deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence","volume":"40","author":"Bagwell","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.01.007_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.pop.2007.04.012","article-title":"ADHD in children, adolescents, and adults","volume":"34","author":"Katragadda","year":"2007","journal-title":"Prim Care"},{"key":"10.1016\/j.jaac.2011.01.007_bib10","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/chi.0b013e318054e724","article-title":"Practice parameter for the assessment and treatment of children and adolescents with attention-deficit\/hyperactivity disorder","volume":"46","author":"Pliszka","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2 Suppl","key":"10.1016\/j.jaac.2011.01.007_bib11","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1097\/00004583-200202001-00003","article-title":"Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults","volume":"41","author":"Greenhill","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.01.007_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/NDT.S9749","article-title":"Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine","volume":"6","author":"Pennick","year":"2010","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.jaac.2011.01.007_bib13","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0149-2918(07)80083-X","article-title":"Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit\/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study","volume":"29","author":"Biederman","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaac.2011.01.007_bib14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1017\/S1092852900016898","article-title":"Long-term effectiveness and safety of lisdexamfetamine dimesylate in school-aged children with attention-deficit\/hyperactivity disorder","volume":"13","author":"Findling","year":"2008","journal-title":"CNS Spectr"},{"key":"10.1016\/j.jaac.2011.01.007_bib15","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4088\/JCP.v69n0903","article-title":"Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder","volume":"69","author":"Adler","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaac.2011.01.007_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1017\/S1092852900024056","article-title":"Long-Term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder","volume":"14","author":"Weisler","year":"2009","journal-title":"CNS Spectr"},{"key":"10.1016\/j.jaac.2011.01.007_bib17","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.biopsych.2007.04.015","article-title":"Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study","volume":"62","author":"Biederman","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaac.2011.01.007_bib18","series-title":"ADHD Rating Scale\u2014IV: Checklists, Norms, and Clinical Interpretation","author":"DuPaul","year":"1998"},{"key":"10.1016\/j.jaac.2011.01.007_bib19","series-title":"ECDEU Assessment Manual for Psychopharmacology","first-page":"218","article-title":"Clinical global impressions","author":"Guy","year":"1976"},{"key":"10.1016\/j.jaac.2011.01.007_bib20","series-title":"Youth Quality of Life Instrument\u2014Research Version (YQOL-R)","year":"2002"},{"key":"10.1016\/j.jaac.2011.01.007_bib21","series-title":"In: Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR","article-title":"Attention-deficit and disruptive behavior disorders","year":"2000"},{"key":"10.1016\/j.jaac.2011.01.007_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1087054707305152","article-title":"The Kiddie-SADS\u2014Present and Lifetime Version","volume":"11","author":"Mattos","year":"2007","journal-title":"J Atten Disord"},{"key":"10.1016\/j.jaac.2011.01.007_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/108705470100500204","article-title":"Validation of the ADHD Rating Scale as a clinician administered and scored instrument","volume":"5","author":"Faries","year":"2001","journal-title":"J Atten Disord"},{"key":"10.1016\/j.jaac.2011.01.007_bib24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/jado.2002.0471","article-title":"Adolescent quality of life, part II: initial validation of a new instrument","volume":"25","author":"Patrick","year":"2002","journal-title":"J Adolesc"},{"key":"10.1016\/j.jaac.2011.01.007_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/jado.2002.0470","article-title":"Adolescent quality of life, part I: conceptual and measurement model","volume":"25","author":"Edwards","year":"2002","journal-title":"J Adolesc"},{"key":"10.1016\/j.jaac.2011.01.007_bib27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/cap.2008.0109","article-title":"Evaluation of patients' and parents' quality of life in a randomized placebo-controlled atomoxetine study in attention-deficit\/hyperactivity disorder","volume":"19","author":"Escobar","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.01.007_bib28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00787-008-0725-5","article-title":"Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit\/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naive Swedish children and adolescents","volume":"18","author":"Svanborg","year":"2009","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.01.007_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11126-008-9070-6","article-title":"Both atomoxetine and stimulants improve quality of life in an ADHD population treated in a community clinic","volume":"79","author":"Bastiaens","year":"2008","journal-title":"Psychiatr Q"},{"key":"10.1016\/j.jaac.2011.01.007_bib30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/cap.2006.16.713","article-title":"Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: what are the long-term health-related quality-of-life outcomes?","volume":"16","author":"Perwien","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.01.007_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00004583-200503000-00008","article-title":"Atomoxetine treatment in children and adolescents with attention-deficit\/hyperactivity disorder and comorbid oppositional defiant disorder","volume":"44","author":"Newcorn","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2011.01.007_bib32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00004703-200406000-00005","article-title":"The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder","volume":"25","author":"Matza","year":"2004","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.jaac.2011.01.007_bib33","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1542\/peds.110.2.258","article-title":"A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit\/hyperactivity disorder","volume":"110","author":"Biederman","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2011.01.007_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1185\/030079906X80639","article-title":"A community assessment, open-label study of the safety, tolerability, and effectiveness of mixed amphetamine salts extended release in school-age children with ADHD","volume":"22","author":"Ambrosini","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaac.2011.01.007_bib35","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1542\/peds.107.1.e10","article-title":"Placebo-controlled evaluation of amphetamine mixture\u2014dextroamphetamine salts and amphetamine salts (Adderall): efficacy rate and side effects","volume":"107","author":"Ahmann","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2011.01.007_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1753-2000-3-17","article-title":"A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit\/hyperactivity disorder","volume":"3","author":"Wigal","year":"2009","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"10.1016\/j.jaac.2011.01.007_bib37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4088\/JCP.v66n0215","article-title":"Blood pressure changes associated with medication treatment of adults with attention-deficit\/hyperactivity disorder","volume":"66","author":"Wilens","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaac.2011.01.007_bib38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/cap.1992.2.279","article-title":"Relative cardiovascular safety of psychostimulants used to treat attention-deficit hyperactivity disorder","volume":"2","author":"Safer","year":"1992","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2011.01.007_bib39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00004583-200105000-00011","article-title":"Short-term cardiovascular effects of methylphenidate and Adderall","volume":"40","author":"Findling","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856711000086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856711000086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T05:52:19Z","timestamp":1543902739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856711000086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0890856711000086"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2011.01.007","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}